期刊文献+

荷卵巢癌裸鼠肿瘤E-cad启动子去甲基化的研究 被引量:2

The Study of E-cadherin Gene Promoter Demethylation in Nude Mice Burdended-Ovarian Cancer
下载PDF
导出
摘要 目的:观察DNA甲基化转移酶(DNMT)抑制剂5-氮杂-2-脱氧胞苷(5-Aza-CdR)联合组蛋白去乙酰化酶(HDAC)抑制剂苯丁酸钠(SPB)对荷卵巢癌细胞系SKOV3裸鼠上皮钙黏素(E-cad)表达的影响。方法:在已建立的卵巢癌裸鼠腹腔移植瘤模型上,分别应用及两者联合应用5-Aza-CdR、SPB,免疫组化法检测腹腔移植瘤中DNMT1、HDAC1及E-cad的表达变化情况;检测各组移植瘤E-cad基因启动子区5CpG岛甲基化状况及移植瘤E-cadmRNA和蛋白的表达情况。结果:(1)在对照组中,DNMT1和HDAC1的阳性表达较多,5-Aza-CdR能抑制DNMT1的表达,SPB能抑制HDAC1的表达,差异有统计学意义(P<0.05)。(2)5-Aza-CdR能够诱导E-cad基因去甲基化,使E-cadmRNA及蛋白恢复表达或者表达增强,联合应用5-Aza-CdR和SPB可更大程度上诱导甲基化的E-cad基因去甲基化而恢复mRNA和E-cad蛋白的表达。结论:5-Aza-CdR能够降低E-cad基因启动子区的甲基化,可恢复其表达;联合应用5-Aza-CdR和SPB可产生协同效应,对卵巢癌的治疗有重要作用。′′ Objective: To evaluate the effect of the DNA methyltransferase (DNMT) inhibitor 5-Aza -2'-deoxycytidine (5-Aza-CdR) combined with histone deaeetylase (HDAC) inhibitor sodium 4-pbenylbutyrate (SPB) on the expression of epi- thelial cadherin (E-cad) of nude mouse model with ovarian cancer cell line SKOV3. Methods: Forty nude mice were implant- ed ovarian cancer cell line SKOV3 into abdominal cavity as the animal model. The models were randomly divided into four groups, 5-Aza-CdR group, SPB group, 5-Aza-CdR+SPB group and control group. The expressions of DNMT1, HDACI and E-cad in the ovarian cancer xenografts were detected by immunohistochemical staining. The CpG island methylation status of E-cadherin promoter region in xenograft tumors were analyzed by methylation specific PCR (MSP). The mRNA and the pro- tein expressions of E-cad were compared between four groups. Results: The positive expressions of DNMT1 and HDAC1 were higher in control group. It was found that 5-Aza-CdR significantly inhibited the expression of DNMT1, and SPB signifi- cantly inhibited the expression of HDAC1 (P 〈 0.05). It was also found that 5-Aza-CdR can induce the demethylation of E-cad gene, which enhanced expressions of E-cad mRNA and protein. Combined with 5-Aza-CdR and SPB induced demeth- ylation of E-cad gene and restored the E-cad mRNA and protein expressions. Conclusion: 5-Aza-CdR can reduce the E-cad gene promoter methylation and restore E-cad mRNA and protein expression. 5-Aza-CdR combined with SPB can ac- complish synergetic effect and enhance the expression of methylated E-cad gene significantly, which play an important role in the treatment of ovarian cancer.
出处 《天津医药》 CAS 北大核心 2012年第6期582-585,I0004,共5页 Tianjin Medical Journal
基金 天津市自然科学基金项目(项目编号:08JCYBJC08200)
关键词 卵巢肿瘤 钙黏着糖蛋白类 脱氧胞苷 丁酸苯酯类 CPG岛 甲基化 小鼠 近交BALB C ovarian neoplasms cadherins deoxycytidine phenylbutyrates CpG islands methylation mice, in-bred BALB C
  • 相关文献

参考文献9

  • 1Fruscio R, Colombo N, Lissoni AA, et al. A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cis- platin, paclitaxel and epirubicin in newly diagnosed advanced epi- thelial ovarian cancer: long-term survival analysis. [J]. Br J Cancer, 2008, 98(4):720-727.
  • 2曲芃芃,高媛,李娜.卵巢上皮性癌组织中E钙黏素基因启动子区甲基化及其表达[J].中华妇产科杂志,2008,43(9):708-710. 被引量:3
  • 3Ohashi K, Nemoto T, Nakamura K,et al. Increased expression of ma- trix metalloproteinase 7 and 9 and membrane type 1-matrix metallo- proteinase in esophageal squamous cell carcinomas[J].Cancer,2000, 88(10):2201-2209.
  • 4Faleiro RC,Macedo PM,Maia SS,et al.Biological relevance of E-cad- herin-catenin complex proteins in primary epithelial ovarian tu- mours [J].Gynecol Obstet Invest,2005,60(2):75-83.
  • 5Imai T,Horiuehi A,Wang C,et al.Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells[J]. Am J Pathol, 2003, 163(4): 1437-1447.
  • 6Kristensen LS, Nielsen HM, Hansen LL.Epigenetics and cancer treatment[J]. Eur J Pharmacol, 2009, 625(1-3): 131-142.
  • 7Halkidou K,Gaughan L,Cook S,et al.Upreguhtion and nuclear re- cruitment of HDAC1 in hormone refractory prostate cancer[J].Pros- tare,2004,59(2): 177-189.
  • 8El-Osta A, Kantharidis P, Zalcberg JR, et al. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation [J]. Mol Cell Biol, 2002,22(6): 184.
  • 9Sharma D, Blum J, Yang X, et al. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative Human breast cancer cells [J]. Mol Endocrinol, 2005,19(7): 1740.

二级参考文献13

  • 1Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Nail Acad Sci USA, 1996, 93: 9821-9826.
  • 2Tamura G, Yin J, Wang S, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst ,2000,92:569-573.
  • 3Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature, 1993,366:362-365.
  • 4Faleiro-Rodrlgues C, Macedo-Pinto I, Pereira D, et al. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas. Ann Onco1,2004,15 : 1535-1542.
  • 5Sumigama S, ho T, Kajiyama H, et al. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha. Oncogene, 2004,23:5496-5504.
  • 6Makarla PB, Saboorian MH, Ashfaq R, et aL Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res, 2005, 11:5365-5369.
  • 7Shieh YS, Shiah SG, Jeng HH, et aL DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer, 2005, 104 : 1013-1021.
  • 8Baffle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadhefin gene expression in epithelial tumor cells. Nat Cell Biol,2000,2:84-89.
  • 9Graft JR, Gabrielson E, Fujii H, et al. Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem, 2000, 275: 2727-2732.
  • 10Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromation. Cell, 1997,88 : 471-481.

共引文献2

同被引文献54

  • 1孙朝阳,李娜,周波,杨宗元,卢运萍,翁丹卉.卵巢癌细胞上皮间质转化及侵袭转移过程中microRNA-9的调控作用[J].肿瘤防治研究,2014,41(4):316-319. 被引量:3
  • 2Mtinz M,Kieu C,Mack B, et al. The carcinoma- associated antigenEpCAM upregulates c-myc and induces cell proliferation[J]. Onco- gene, 2004, 23(24): 5748-5758.
  • 3Gastl G, Spizzo G, Obrist P, etal. Ep-CAM overexpression in breast cancer as a predictor of survival[J]. Lancet, 2000, 356(9246): 1981-1982.
  • 4Joo YE, Rew JS, Park CS, et al. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma[J]. Pancreatology, 2002, 2(2): 129-137.
  • 5Maetzel D, Denzel S, Mack B, et al. Nucleatr signalling by tu- mor-associated antigen EpCAM[J]. Nat cell Biol, 2009,11(2): 162-171.
  • 6Stoccklein NH, Siegmund A, Scheunemann P, et al. EpCAM expres. sion in squamous cell carcinoma of the esophagus: a potential thera. peutic target and prognostic marker[J]. BMC Cancer, 2006, 6: 165.
  • 7Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in Breast cancer and is a potential target for breast cancer gene thera- py[J]. Cancer Res, 2004, 64(16): 5818-5824.
  • 8Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epitheli- al transition in development and disease[J]. Cells Tissues Organs, 2007, 185(1-3):7-19.
  • 9Ngan CY, Yamamoto H, Seshimo I, et al. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer [J]. J Surg Oncol, 2007, 95(8):652-662.
  • 10Singhai R, Patil VW, Jaiswal SR, et al. E-Cadherin as a diagnostic biomarker in breast cancer[J]. N Am J Med Sci,2011, 3(5): 227-233.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部